These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 6299860)
21. Detection of Epstein-Barr virus-infected mucosal lymphocytes in nasal polyps. Tao Q; Srivastava G; Dickens P; Ho FC Am J Pathol; 1996 Oct; 149(4):1111-8. PubMed ID: 8863660 [TBL] [Abstract][Full Text] [Related]
22. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV. Yalamanchili R; Tong X; Grossman S; Johannsen E; Mosialos G; Kieff E Virology; 1994 Nov; 204(2):634-41. PubMed ID: 7941331 [TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus (EBV)-induced long-term proliferation of CD4+ lymphocytes leading to T lymphoblastoid cell lines carrying EBV. Guan M; Romano G; Henderson EE Anticancer Res; 1999; 19(4B):3007-17. PubMed ID: 10652585 [TBL] [Abstract][Full Text] [Related]
24. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282 [TBL] [Abstract][Full Text] [Related]
25. In situ RT-PCR detection of Epstein-Barr virus immediate-early transcripts in CD4+ and CD8+ T lymphocytes. Guan M; Romano G; Henderson EE Anticancer Res; 1998; 18(5A):3171-80. PubMed ID: 9858880 [TBL] [Abstract][Full Text] [Related]
27. Cyclosporine promotes epstein-barr virus-infected human B-cell transformation assayed by three correlated assay methods. Chen C; Johnston TD; Jeon H; Gedaly R; McHugh P; Ranjan D Transplant Proc; 2009; 41(1):366-70. PubMed ID: 19249558 [TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese. Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607 [TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus infection of rat lymphocytes expressing human CD21 results in restricted latent viral gene expression and not in immunoblastic transformation. Yang L; Ikeda H; Lai Y; Yoshiki T; Takada K J Med Virol; 2003 May; 70(1):126-30. PubMed ID: 12629653 [TBL] [Abstract][Full Text] [Related]
30. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines. Kriauciunas KM; Goldstein BJ; Lipes MA; Kahn CR J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208 [TBL] [Abstract][Full Text] [Related]
31. [Epstein-Barr virus-specific immunity in asymptomatic carriers of human T-cell leukemia virus type 1]. Kwon KW Hokkaido Igaku Zasshi; 1995 Mar; 70(2):315-28. PubMed ID: 7774883 [TBL] [Abstract][Full Text] [Related]
32. Effects of nucleoside analogs on Epstein-Barr virus-induced transformation of human umbilical cord leukocytes and Epstein-Barr virus expression in transformed cells. Henderson EE; Long WK; Ribecky R Antimicrob Agents Chemother; 1979 Jan; 15(1):101-10. PubMed ID: 218497 [TBL] [Abstract][Full Text] [Related]
33. Reversible inhibition by phosphonoacetic acid of human B lymphocyte transformation by Epstein-Barr virus. Thorley-Lawson DA; Strominger JL Virology; 1978 May; 86(2):423-31. PubMed ID: 208257 [No Abstract] [Full Text] [Related]
34. Core (2'-5')oligoadenylate and the cordycepin analog: inhibitors of Epstein--Barr virus-induced transformation of human lymphocytes in the absence of interferon. Doetsch PW; Suhadolnik RJ; Sawada Y; Mosca JD; Flick MB; Reichenbach NL; Dang AQ; Wu JM; Charubala R; Pfleiderer W; Henderson EE Proc Natl Acad Sci U S A; 1981 Nov; 78(11):6699-703. PubMed ID: 6171822 [TBL] [Abstract][Full Text] [Related]
35. Dehydroepiandrosterone and 16 alpha-bromo-epiandrosterone: inhibitors of Epstein-Barr virus-induced transformation of human lymphocytes. Henderson E; Schwartz A; Pashko L; Abou-Gharbia M; Swern D Carcinogenesis; 1981; 2(7):683-6. PubMed ID: 6268330 [TBL] [Abstract][Full Text] [Related]
36. DNA and protein synthesis in normal and transformed lymphocytes exposed to abrin. Bennett CE; Glassman AB; Witten M Pharmacol Biochem Behav; 1982 Jan; 16(1):185-8. PubMed ID: 6276906 [TBL] [Abstract][Full Text] [Related]
37. Biologic properties of human herpesvirus 7 strain SB. Black JB; Burns DA; Goldsmith CS; Feorino PM; Kite-Powell K; Schinazi RF; Krug PW; Pellett PE Virus Res; 1997 Nov; 52(1):25-41. PubMed ID: 9453142 [TBL] [Abstract][Full Text] [Related]
38. Organophosphorous compounds as inhibitors of EBV infection and transformation. Margalith M; Manor D; Goldblum N Dev Biol Stand; 1982; 52():515-26. PubMed ID: 6299860 [TBL] [Abstract][Full Text] [Related]
39. Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV. Margalith M; Manor D; Agranat I; Bentor Y; Gelfand T; Goldblum N Cancer Biochem Biophys; 1980; 4(3):137-43. PubMed ID: 6254633 [TBL] [Abstract][Full Text] [Related]
40. Phosphonoacetic acid: inhibition of transformation of human cord blood lymphocytes by Epstein-Barr virus. Manor D; Margalith M Cancer Biochem Biophys; 1979; 3(4):157-62. PubMed ID: 233303 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]